Giulian D, Chen J, Ingeman J E, George J K, Noponen M
Department of Neurology, Baylor College of Medicine, Houston, Texas 77031.
J Neurosci. 1989 Dec;9(12):4416-29. doi: 10.1523/JNEUROSCI.09-12-04416.1989.
We monitor cellular responses to a penetrating wound in the cerebral cortex of adult rat during the first weeks after injury. Two classes of activated mononuclear phagocytes containing acetylated low-density lipoprotein (ac-LDL) receptors appear within hours at the wound site. One type of cell surrounding the lesion edge had thin, delicate processes and is identical in appearance to ramified microglia found in developing brain. Within the lesion, round cells are recognized as blood-borne macrophages when labeled by intravenous injection of carbon particles. Thus, both process-bearing reactive microglia and invading macrophages respond to brain trauma. The greatest number of ac-LDL(+) or nonspecific esterase(+) mononuclear phagocytes appears 2 days after injury within the wound site and are associated with a peak production of the cytokine interleukin-1 (IL-1). Because intracerebral infusion of IL-1 is known to stimulate astrogliosis and neovascularization (Giulian et al., 1988), we examine the time course of injury-induced reactive astrogliosis and angiogenesis. A 5-fold increase in the number of reactive astroglia is found at 3 d and a marked neovascularization at 5 d after injury. During the first week, mononuclear phagocytes engulf particles and clear them from the wound site either by migrating to the brain surface or by entering newly formed brain vasculature. To investigate further the role of reactive brain mononuclear phagocytes in CNS injury, we use drugs to inhibit trauma-induced inflammation. When applied in vivo, chloroquine or colchicine reduce the number of mononuclear phagocytes in damaged brain, help to block reactive astrogliosis and neovascularization, and slow the rate of debris clearance from sites of traumatic injury. In contrast, the glucocorticoid dexamethasone neither reduces the number of brain inflammatory cells nor hampers such responses as phagocytosis, astrogliosis, neovascularization, or debris clearance in vivo. Our observations show that mononuclear phagocytes play a major role in wound healing after CNS trauma with some events controlled by secretion of cytokines. Moreover, certain classes of immunosuppressive drugs may be useful in the treatment of acute brain injury.
我们在成年大鼠脑皮质穿透伤后的最初几周内监测细胞反应。损伤后数小时内,伤口部位出现两类含有乙酰化低密度脂蛋白(ac-LDL)受体的活化单核吞噬细胞。一类围绕损伤边缘的细胞具有细长、精致的突起,外观与发育中脑内的分支状小胶质细胞相同。在损伤部位,静脉注射碳颗粒标记后,圆形细胞被识别为血源性巨噬细胞。因此,具有突起的反应性小胶质细胞和侵入的巨噬细胞均对脑损伤作出反应。损伤后2天,伤口部位出现数量最多的ac-LDL(+)或非特异性酯酶(+)单核吞噬细胞,且与细胞因子白细胞介素-1(IL-1)的峰值产生相关。由于已知脑内注入IL-1可刺激星形胶质细胞增生和新生血管形成(朱利安等人,1988年),我们研究了损伤诱导的反应性星形胶质细胞增生和血管生成的时间进程。损伤后3天发现反应性星形胶质细胞数量增加5倍,5天出现明显的新生血管形成。在第一周内,单核吞噬细胞通过迁移至脑表面或进入新形成的脑血管系统吞噬颗粒并将其从伤口部位清除。为进一步研究反应性脑单核吞噬细胞在中枢神经系统损伤中的作用,我们使用药物抑制创伤诱导的炎症。体内应用氯喹或秋水仙碱可减少受损脑内单核吞噬细胞数量,有助于阻断反应性星形胶质细胞增生和新生血管形成,并减缓创伤部位碎片清除速度。相比之下,糖皮质激素地塞米松既不减少脑内炎性细胞数量,也不阻碍体内吞噬作用、星形胶质细胞增生、新生血管形成或碎片清除等反应。我们的观察结果表明,单核吞噬细胞在中枢神经系统创伤后的伤口愈合中起主要作用,某些事件受细胞因子分泌控制。此外,某些种类的免疫抑制药物可能对急性脑损伤的治疗有用。